Merck | MRK - Net Income



Merck reported EUR652M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Adidas EUR 369M 59M Jun/2025
Adyen EUR 515.55M 310.74M Dec/2024
Akzo Nobel EUR 124M 17M Jun/2025
Alcon AG USD 176M 174M Jun/2025
Amadeus IT EUR 372.1M 16.7M Jun/2025
Amarin USD -15697000 32.92M Mar/2025
AstraZeneca USD 2.45B 466M Jun/2025
BASF EUR 79M 729M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Beiersdorf EUR 552M 222M Jun/2025
Covestro EUR -59000000 101M Jun/2025
Danone EUR 1.04B 236M Jun/2025
Fresenius EUR 330M 101M Jun/2025
Fresenius Medical Care EUR 225M 74M Jun/2025
Galapagos EUR -105748000 47.66M Jun/2025
Genmab DKK 336M 141M Jun/2025
Givaudan CHF 294M 150M Jun/2024
GlaxoSmithKline GBP 1.44B 181M Jun/2025
GRIFOLS EUR 117.06M 57.34M Jun/2025
Henkel EUR 1.11B 132M Jun/2025
Hikma Pharmaceutical USD 133M 93M Dec/2024
Infineon EUR 301M 69M Jun/2025
Linde USD 1.77B 41M Jun/2025
Lonza CHF 307M 22M Dec/2024
Merck EUR 652M 83M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Philips EUR 240M 165M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Sanofi EUR 3.94B 2.07B Jun/2025
UCB EUR 857M 649M Dec/2024